Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04444635Completed
Randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Cairo University. Primary endpoint: The total dose of postoperative operative fentanyl consumption in the first 24 hours. Started Jun 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04444635.